Journal article
Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment
Abstract
The nonvitamin K antagonist oral anticoagulants (NOACs), also referred to as direct oral anticoagulants (DOACs), dabigatran, apixaban, edoxaban, and rivaroxaban, have emerged as effective alternatives to vitamin K antagonists (VKAs) across several indications, including the prevention of stroke and systemic embolism (SSE) in patients with atrial fibrillation (AF) and the treatment of venous thromboembolism (VTE). Their use in patients with …
Authors
Turpie AGG; Purdham D; Ciaccia A
Journal
Therapeutic Advances in Cardiovascular Disease, Vol. 11, No. 9, pp. 243–256
Publisher
SAGE Publications
Publication Date
September 2017
DOI
10.1177/1753944717714921
ISSN
1753-9447